Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, Mediated
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Mineralocorticoid receptors, both when in tissue extracts and when recombinant-derived, have equal affinity for the physiological mineralocorticoid aldosterone and for the glucocorticoids cortisol and corticosterone, which circulate at much higher concentrations than aldosterone. Such receptors are found in physiological mineralocorticoid target tissues (kidney, parotid, and colon) and in nontarget tissues such as hippocampus and heart. In mineralocorticoid target tissues the receptors are selective for aldosterone in vivo because of the presence of the enzyme 11 β-hydroxy-steroid dehydrogenase, which converts cortisol and corticosterone, but not aldosterone, to their 11-keto analogs. These analogs cannot bind to mineralocorticoid receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mineralocorticoid-responsive tissues such as the kidney, cortisol is enzymatically converted to cortisone, a metabolically inactive steroid (569).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, the type 2 enzyme inactivates the mineralocorticoid activity of cortisol in the kidney tubule (569), and inactivating mutations in the type 2 enzyme cause a syndrome of apparent mineralocorticoid excess (AME) (588).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, 11HSD2 prevents cortisol from overwhelming renal mineralocorticoid receptors (569), and in the placenta and other fetal tissues 11HSD2 (583, 584) also inactivates cortisol.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“The kidney has high levels of HSD11B2 activity which protects the mineralocorticoid receptor from activation by cortisol by inactivating it to cortisone (Edwards and Stewart, 1991, Funder et al., 1988).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Funder et al., 1988
Citations
Cites
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Stewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803
Krozowski, Z. S., & Funder, J. W. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.6056 · Cited by 523
Self-citationThe Roles of Plasma Binding and Receptor Specificity in the Mineralocorticoid Action of Aldosterone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-994 · Cited by 232
Self-citationCharacterization of Rat Brain Aldosterone Receptors Reveals High Affinity for Corticosterone
BEAUMONT, K., & FANESTIL, D. D. (1983) · Endocrinology · doi:10.1210/endo-113-6-2043 · Cited by 193
Pearson Murphy, B. E. (1981) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(81)90226-0 · Cited by 178
Glucocorticoid Receptors in Rat Kidney: The Rinding of Tritiated-Dexamethasone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-1005 · Cited by 173
Self-citationAFFINITY OF LIQUORICE DERIVATIVES FOR MINERALOCORTICOID AND GLUCOCORTICOID RECEPTORS
ARMANINI, D., KARBOWIAK, I., & FUNDER, J. W. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb00038.x · Cited by 157
Self-citationGlucocorticoid and mineralocorticoid receptors for aldosterone
Rousseau, G. G., Baxter, J. D., Funder, J. W., Edelman, I. S., & Tomkins, G. M. (1972) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(72)90053-2 · Cited by 151
Self-citation
Research works printed but not linked: 4
- Krozowski, Z. S., Proceedings of the National Academy of Sciences of the United States of America 80: 6056 (1983).
- SHEPPARD, K, MINERALOCORTICOID SPECIFICITY OF RENAL TYPE-I RECEPTORS - INVIVO BINDING-STUDIES, AMERICAN JOURNAL OF PHYSIOLOGY 252: E224 (1987).
- SHEPPARD, K, TYPE-I RECEPTORS IN PAROTID, COLON, AND PITUITARY ARE ALDOSTERONE SELECTIVE INVIVO, AMERICAN JOURNAL OF PHYSIOLOGY 253: E467 (1987).
- STEWART, P.M., CORTICOSTEROIDS PEPT 39: 163 (1987).
Cited by
Items 101–200 of 1,001
Intracrine androgen biosynthesis, metabolism and action revisited
Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217
“The kidney has high levels of HSD11B2 activity which protects the mineralocorticoid receptor from activation by cortisol by inactivating it to cortisone (Edwards and Stewart, 1991; Funder et al., 1988).”
Glycyrrhizic acid in liquorice—Evaluation of health hazard
Størmer, F. C., Reistad, R., & Alexander, J. (1993) · Food and Chemical Toxicology · doi:10.1016/0278-6915(93)90080-i · Cited by 214
Control of transcription activation by steroid hormone receptors
Gronemeyer, H. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.8.1592204 · Cited by 214
“For the PR, hormone binding is the prerequisite to interact with DNA both in vitro and in vivo (19).”
BackgroundAldosterone and end-organ damage
Marney, A. M., & Brown, N. J. (2007) · Clinical Science · doi:10.1042/cs20070123 · Cited by 212
Angulo, J. A., & McEwen, B. S. (1994) · Brain Research Reviews · doi:10.1016/0165-0173(94)90002-7 · Cited by 212
Kupari, M., Hautanen, A., Lankinen, L., Koskinen, P., Virolainen, J., Nikkila, H., & White, P. C. (1998) · Circulation · doi:10.1161/01.cir.97.6.569 · Cited by 211
Glucocorticoids and stress: permissive and suppressive actions
MUNCK, A., & NÁRAY‐FEJES‐TÓTH, A. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb39221.x · Cited by 209
From Receptor Balance to Rational Glucocorticoid Therapy
de Kloet, E. R. (2014) · Endocrinology · doi:10.1210/en.2014-1048 · Cited by 208
“But why does brain MR respond to B, while the kidney MR responds selectively to aldosterone in the regulation of sodium homeostasis? In 1988, 2 studies pointed to 11 hydroxysteroid dehydrogenase type 2 (11 HSD-2) as an enzyme capable in kidney epithelial cells of inactivating F and B but not aldosterone (32, 33).”
BackgroundTempel, D. L., & Leibowitz, S. F. (1994) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1994.tb00611.x · Cited by 206
“activity that favors the binding of ALDO (76, 82, 163).”
BackgroundInfluentialMcEwen, B. S., Gould, E. A., & Sakai, R. R. (1992) · British Journal of Psychiatry · doi:10.1192/s0007125000296645 · Cited by 206
Regulation of adrenocorticosteroid receptor mRNA expression in the central nervous system
Herman, J. P. (1993) · Cellular and Molecular Neurobiology · doi:10.1007/bf00711577 · Cited by 204
Successful Long-Term Treatment of Refractory Cushing's Disease with High-Dose Mifepristone (RU 486)
Chu, J. W. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3568 · Cited by 200
“These clinical effects may be attributable to abnormal overactivation of MR. In physiological settings, the enzyme 11-hydroxysteroid dehydrogenase (11HSD) converts cortisol, an avid GR- and MR-binding glucocorticoid, to its 11-keto analog (cortisone), a non-GR, non-MR-binding glucocorticoid ( 12 ).”
BackgroundImmunohistochemical Localization of Type 1 11β-Hydroxysteroid Dehydrogenase in Human Tissues1
Ricketts, M. L., Verhaeg, J. M., Bujalska, I., Howie, A. J., Rainey, W. E., & Stewart, P. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4706 · Cited by 197
“Although 11bHSD1 was the first enzyme to be characterized and cloned in rodent and human tissues (1, 13), there has been recent interest in the 11bHSD2 isozyme (2), principally because of its role in protecting the mineralocorticoid receptor from cortisol excess (14, 15) and its association with human hypertension (7–…”
BackgroundCloning and production of antisera to human placental 11 β-hydroxysteroid dehydrogenase type 2
BROWN, R. W., CHAPMAN, K. E., KOTELEVTSEV, Y., YAU, J. L. W., LINDSAY, R. S., BRETT, L., LECKIE, C., MURAD, P., LYONS, V., MULLINS, J. J., et al. (1996) · Biochemical Journal · doi:10.1042/bj3131007 · Cited by 196
A molecular framework for the actions of glucocorticoid hormones in the nervous system
Evans, R. M., & Arriza, J. L. (1989) · Neuron · doi:10.1016/0896-6273(89)90177-3 · Cited by 196
Adrenal Corticosteroid Biosynthesis, Metabolism, and Action
Arlt, W., & Stewart, P. M. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.002 · Cited by 195
“The NADdependent dehydrogenase, 11b-HSD2, is coexpressed with the MR in the kidney, colon, and salivary gland and inactivates cortisol to cortisone, thereby enabling aldosterone to bind to the MR in vivo [48,49].”
BackgroundImmune regulation by glucocorticoids can be linked to cell type–dependent transcriptional responses
Franco, L. M., Gadkari, M., Howe, K. N., Sun, J., Kardava, L., Kumar, P., Kumari, S., Hu, Z., Fraser, I. D. C., Moir, S., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180595 · Cited by 194
“Some of these differences may be the result of variation in the levels of the type II isozyme of 11β-hydroxysteroid dehydrogenase (11βHSD2) or of the β isoform of the GR (GRβ) across cell types, both of which are known to decrease the overall sensitivity of cells to glucocorticoids (Funder et al., 1988; Lu et al., 200…”
BackgroundPanarelli, M., Holloway, C. D., Fraser, R., Connell, J. M. C., Ingram, M. C., Anderson, N. H., & Kenyon, C. J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4828 · Cited by 150
“Renal mineralocorticoid receptors are normally protected from endogenous glucocorticoid hormones by 11b-HSD (12, 13 ), but hypertension can arise if plasma cortisol overwhelms this protective mechanism (11, 43, 44).”
BackgroundOdermatt, A., Arnold, P., Stauffer, A., Frey, B. M., & Frey, F. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28762 · Cited by 190
Yau, J. L. W., Noble, J., Kenyon, C. J., Hibberd, C., Kotelevtsev, Y., Mullins, J. J., & Seckl, J. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071562698 · Cited by 190
11β-Hydroxysteroid Dehydrogenase
Monder, C., & White, P. C. (1993) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60447-1 · Cited by 189
Shibata, S., Rinehart, J., Zhang, J., Moeckel, G., Castañeda-Bueno, M., Stiegler, A. L., Boggon, T. J., Gamba, G., & Lifton, R. P. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.005 · Cited by 188
“Lastly, 11bHSD2, which metabolizes cortisol to the inactive metabolite cortisone (Funder et al., 1988), is thought to be absent Inc. in some cell types that expressMR (Kyossev et al., 1996; Nguyen DinhCat et al., 2010), posing the question of howMR is regulated in these cells.”
InfluentialLi, Y., Suino, K., Daugherty, J., & Xu, H. E. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.026 · Cited by 187
“The physiological hormone for MR is aldosterone in humans and corticosterone in rodents (Funder et al., 1988).”
Background11β-hydroxysteroid dehydrogenases: changing glucocorticoid action
Seckl, J. R. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.09.001 · Cited by 185
Booth, R. E., Johnson, J. P., & Stockand, J. D. (2002) · Advances in Physiology Education · doi:10.1152/advan.00051.2001 · Cited by 125
“In a landmark paper, Funder and colleagues (18) advanced the hypothesis that 11 -HSD2 served to protect the MR from glucocorticoid occupancy by metabolizing glucocorticoids to products with markedly reduced affinity for MR.”
BackgroundCooper, M. S., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1412 · Cited by 183
Connell, J. M. C., MacKenzie, S. M., Freel, E. M., Fraser, R., & Davies, E. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0030 · Cited by 182
Geerling, J. C., & Loewy, A. D. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90399.2008 · Cited by 182
“The fact that a compound in liquorice produces mineralocorticoidlike physiological changes by altering urinary glucocorticoid metabolism (163), combined with a similar metabolic phenotype observed in patients with the heritable syndrome of apparent mineralocorticoid excess (162, 169), led to the discovery that the ind…”
BackgroundThe role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension
Ferrari, P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.017 · Cited by 181
“T E The 11ßHSD enzymes catalyse the interconversion of cortisol and cortisone in humans (Figure 2), and of corticosterone and dehydrocorticosterone in rodents [7].”
Kolkhof, P., Jaisser, F., Kim, S.-Y., Filippatos, G., Nowack, C., & Pitt, B. (2016) · Handbook of Experimental Pharmacology · doi:10.1007/164_2016_76 · Cited by 180
Genetic dissection of glucocorticoid receptor function in mice
Tronche, F., Kellendonk, C., Reichardt, H. M., & Schütz, G. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80007-5 · Cited by 180
Tumor Necrosis Factor α and Interleukin 1β Enhance the Cortisone/Cortisol Shuttle
Escher, G., Galli, I., Vishwanath, B. S., Frey, B. M., & Frey, F. J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.189 · Cited by 179
“The biological activity of glucocorticosteroids depends on their dose, metabolism, local access to their cognate receptors, and on the responsiveness of the target cells (8, 9).”
Mineralocorticoid receptors in vascular function and disease
McCurley, A., & Jaffe, I. Z. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.014 · Cited by 178
“Although plasma glucocorticoid concentrations are higher than those of Aldo, Aldo-responsive tissues, such as the kidney, maintain Aldo responsiveness by expressing the cortisol-inactivating enzyme 11-beta-hydroxysteroid dehydrogenase type 2 (11ßHSD2, (Funder et al., 1988)).”
BackgroundStress and Depression: a Crucial Role of the Mineralocorticoid Receptor
de Kloet, E. R., Otte, C., Kumsta, R., Kok, L., Hillegers, M. H. J., Hasselmann, H., Kliegel, D., & Joëls, M. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12379 · Cited by 178
“Third, as mentioned, bio-availability also depends on the intracellular enzyme 11βhydroxysteroid dehydrogenase type 2 (11β-HSD type 2) which oxidizes bio-active cortisol or corticosterone to its inactive 11-dehydro metabolite, leaving aldosterone as preferred ligand of MR (11,12).”
Whorwood, C. B. (1993) · Endocrinology · doi:10.1210/en.132.6.2287 · Cited by 178
Moore, J. S., Monson, J. P., Kaltsas, G., Putignano, P., Wood, P. J., Sheppard, M. C., Besser, G. M., Taylor, N. F., & Stewart, P. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6108 · Cited by 154
de Kloet, E. R., Reul, J. M. H. M., & Sutanto, W. (1990) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(90)90489-8 · Cited by 175
The Serum- and Glucocorticoid-Induced Kinase Is a Physiological Mediator of Aldosterone Action
Bhargava, A. (2001) · Endocrinology · doi:10.1210/en.142.4.1587 · Cited by 174
Self-citationDeficient inactivation of cortisol by 11β‐hydroxysteroid dehydrogenase in essential hypertension
Walker, B. R., Stewart, P. M., Shackleton, C. H. L., Padfield, P. L., & Edwards, C. R. W. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb01778.x · Cited by 174
Lin, S.-H. (2001) · QJM · doi:10.1093/qjmed/94.3.133 · Cited by 173
TORPY, D. J., MULLEN, N., ILIAS, I., & NIEMAN, L. K. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04419.x · Cited by 173
Rajan, V, Edwards, C., & Seckl, Jr. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00065.1996 · Cited by 171
Hypokalemia--consequences, causes, and correction.
Weiner, I. D., & Wingo, C. S. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v871179 · Cited by 171
Lombes, M. (1994) · Endocrinology · doi:10.1210/en.135.3.834 · Cited by 151
Walker, B. R., Campbell, J. C., Fraser, R., Stewart, P. M., & Edwards, C. R. W. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb01478.x · Cited by 170
Glucocorticoid signalling—multiple variations of a common theme
Reichardt, H. M., & Schütz, G. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00208-1 · Cited by 170
11β-Hydroxysteroid dehydrogenases: Key enzymes in determining tissue-specific glucocorticoid effects
Edwards, C. R. W., Benediktsson, R., Lindsay, R. S., & Seckl, J. R. (1996) · Steroids · doi:10.1016/0039-128x(96)00033-5 · Cited by 169
Spencer, R. L. (1998) · Endocrinology · doi:10.1210/en.139.6.2718 · Cited by 169
Funder, J. (1996) · Endocrinology · doi:10.1210/en.137.12.5264 · Cited by 154
Self-citationRole of 11β-Hydroxysteroid Dehydrogenase in Nongenomic Aldosterone Effects in Human Arteries
Alzamora, R., Michea, L., & Marusic, E. T. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1099 · Cited by 168
Mineralocorticoids, Glucocorticoids, Receptors and Response Elements
Funder, J. W. (1993) · Science · doi:10.1126/science.8382375 · Cited by 168
Self-citationThe Role of Aldosterone in Obesity-Related Hypertension
Kawarazaki, W., & Fujita, T. (2016) · American Journal of Hypertension · doi:10.1093/ajh/hpw003 · Cited by 165
Kusakabe, M., Nakamura, I., & Young, G. (2003) · Endocrinology · doi:10.1210/en.2002-220446 · Cited by 165
Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess
New, M. I., & Wilson, R. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12790 · Cited by 164
Structural and functional biology of aldo-keto reductase steroid transforming enzymes
Penning, T. M., Wangtrakuldee, P., & Auchus, R. J. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00089 · Cited by 164
Cole, T. J., Short, K. L., & Hooper, S. B. (2019) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2019.05.005 · Cited by 164
ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension
Gomez-Sanchez, E. P., Venkataraman, M. T., Thwaites, D., & Fort, C. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.4.e649 · Cited by 164
Soro, A., Ingram, M. C., Tonolo, G., Glorioso, N., & Fraser, R. (1995) · Hypertension · doi:10.1161/01.hyp.25.1.67 · Cited by 164
Sun, K., Yang, K., & Challis, J. R. G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3681 · Cited by 163
Chantong, B., Kratschmar, D. V., Nashev, L. G., Balázs, Z., & Odermatt, A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-260 · Cited by 163
“In classical mineralocorticoid target tissues involved in electrolyte and volume regulation, such as renal cortical collecting ducts, distal colon, and salivary and sweat glands, MR is co-expressed with 11β-hydroxysteroid dehydrogenase 2 (11β-HSD2), which converts active (corticosterone, cortisol) into inactive glucoc…”
BackgroundMolecular Basis of Human Salt Sensitivity: The Role of the 11β-Hydroxysteroid Dehydrogenase Type 2*
Lovati, E., Ferrari, P., Dick, B., Jostarndt, K., Frey, B. M., Frey, F. J., Schorr, U., & Sharma, A. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6098 · Cited by 142
Mineralocorticoid hypertension
Stewart, P. M. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06102-9 · Cited by 162
Goding, J. W., Terkeltaub, R. A., Maurice, M., Déterre, P., Sali, A., & Belli, S. I. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01568.x · Cited by 162
Trapp, T., & Holsboer, F. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)81590-2 · Cited by 162
Gluco- and antimineralocorticoid effects on human sleep: a role of central corticosteroid receptors
Born, J., DeKloet, E. R., Wenz, H., Kern, W., & Fehm, H. L. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.2.e183 · Cited by 161
WALKER, B. R., YAU, J. L., BRETT, L. P., SECKL, J. R., MONDER, C., WILLIAMS, B. C., & EDWARDS, C. R. W. (1991) · Endocrinology · doi:10.1210/endo-129-6-3305 · Cited by 142
Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor
Lu, N. Z., Collins, J. B., Grissom, S. F., & Cidlowski, J. A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00253-07 · Cited by 160
“Although tissue-selective ligand availability and cofactor recruitment can partially explain the cell typeselective effects of glucocorticoids (1, 9, 11, 12), recent evidence suggests that tissue-selective expression of glucocorticoid receptor (GR) isoforms may also play a critical role in the tissue-selective respons…”
BackgroundHellal-Levy, C., Couette, B., Fagart, J., Souque, A., Gomez-Sanchez, C., & Rafestin-Oblin, M.-E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01667-1 · Cited by 160
Kralli, A., Bohen, S. P., & Yamamoto, K. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4701 · Cited by 160
Odermatt, A., & Kratschmar, D. V. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.020 · Cited by 159
Human Mineralocorticoid Receptor Genomic Structure and Identification of Expressed Isoforms
Zennaro, M.-C., Keightley, M.-C., Kotelevtsev, Y., Conway, G. S., Soubrier, F., & Fuller, P. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.21016 · Cited by 159
Reconsidering the Roles of the Mineralocorticoid Receptor
Funder, J. W. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.119966 · Cited by 159
Self-citationLicorice-Induced Hypertension and Syndromes of Apparent Mineralocorticoid Excess
Walker, B. R., & Edwards, C. R. W. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30102-6 · Cited by 159
Eplerenone: Cardiovascular Protection
Brown, N. J. (2003) · Circulation · doi:10.1161/01.cir.0000071081.35693.9a · Cited by 158
11&Bgr;-Hydroxysteroid Dehydrogenase Type 1 and Obesity
Morton, N. M., & Seckl, J. R. (2008) · Frontiers of Hormone Research · doi:10.1159/000115363 · Cited by 134
Stress in Atlantic salmon: response to unpredictable chronic stress
Madaro, A., Olsen, R. E., Kristiansen, T., Ebbesson, L. O. E., Nilsen, T. O., Flik, G., & Gorissen, M. (2015) · Journal of Experimental Biology · doi:10.1242/jeb.120535 · Cited by 157
“This enzyme catalyses the degradation of cortisol to cortisone, thus regulating cortisol availability to corticoid receptors (Funder et al., 1988).”
The type I and type II 11β-hydroxysteroid dehydrogenase enzymes
Krozowski, Z. S., Li, K. X. Z., Koyama, K., Smith, R. E., Obeyesekere, V. R., Stein, A., Sasano, H., Coulter, C., Cole, T. J., & Sheppard, K. E. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00074-6 · Cited by 157
Self-citationAldosterone-sensitive neurons in the rat central nervous system
Geerling, J. C., Kawata, M., & Loewy, A. D. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20808 · Cited by 145
“Its secretory products may play a role in neural development (Gobron et al., 1996).”
BackgroundExpression of 11β-hydroxysteroid dehydrogenase using recombinant vaccinia virus
Agarwal, A. K., Tusie-Luna, M.-T., Monder, C., & White, P. C. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-12-1827 · Cited by 155
Takahashi, H., & Sakamoto, T. (2012) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2012.11.016 · Cited by 155
Seckl, J. R., & Walker, B. R. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.09.007 · Cited by 154
Aldosterone Target Neurons in the Nucleus Tractus Solitarius Drive Sodium Appetite
Geerling, J. C., Engeland, W. C., Kawata, M., & Loewy, A. D. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3115-05.2006 · Cited by 147
“1, available at www.jneurosci. org as supplemental material) (Funder et al., 1988); (3) they must be accessible to aldosterone.”
BackgroundRole of glucocorticoid in developmental programming: Evidence from zebrafish
Nesan, D., & Vijayan, M. M. (2012) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2012.10.006 · Cited by 153
Immune Effects of Corticosteroids in Sepsis
Heming, N., Sivanandamoorthy, S., Meng, P., Bounab, R., & Annane, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01736 · Cited by 153
Sayegh, R., Auerbach, S. D., Li, X., Loftus, R. W., Husted, R. F., Stokes, J. B., & Thomas, C. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12431 · Cited by 139
Placental 11 beta-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoids
Yang, K. P. (1997) · Reviews of Reproduction · doi:10.1530/revreprod/2.3.129 · Cited by 131
Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action
Penning, T. M. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg022 · Cited by 140
“11b-HSDs as prototypic SIM-targets The differential effects of the human 11b-HSD isoforms provides a compelling example of how HSD isoforms regulate steroid hormone action at the pre-receptor level (Funder et al., 1988).”
Aldosterone as a cardiovascular risk factor
Rossi, G. P., Boscaro, M., Ronconi, V., & Funder, J. W. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.02.010 · Cited by 148
Self-citationMedicinal uses of licorice through the millennia: The good and plenty of it
Davis, E. A., & Morris, D. J. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90179-v · Cited by 148
CAMPBELL, S., Janicki, J., & Weber, K. T. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(95)90359-3 · Cited by 148
Fairbrother, A., Smits, J. E. G., & Grasman, K. A. (2004) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937400490258873 · Cited by 146
“These receptors have equally high affinity for the endogenous glucocorticoids (cortisol and corticosterone) and aldosterone (Funder et al., 1988).”
BackgroundLocalization of 11 beta-hydroxysteroid dehydrogenase type II in human epithelial tissues.
Smith, R. E., Maguire, J. A., Stein-Oakley, A. N., Sasano, H., Takahashi, K., Fukushima, K., & Krozowski, Z. S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784076 · Cited by 146
Self-citationGlucocorticoid-mediated mineralocorticoid receptor activation and hypertension
Frey, F. J., Odermatt, A., & Frey, B. M. (2004) · Current Opinion in Nephrology and Hypertension · doi:10.1097/01.mnh.0000133976.32559.b0 · Cited by 137
Condon, J., Gosden, C., Gardener, D., Nickson, P., Hewison, M., Howie, A. J., & Stewart, P. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5302 · Cited by 125
Joëls, M., & de Kloet, E. R. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0660 · Cited by 146
Kiilerich, P., Kristiansen, K., & Madsen, S. S. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0185 · Cited by 145
“Colocalization of the 11bhydroxysteroid dehydrogenase 2 enzyme, which converts cortisol to the receptor inactive cortisone (Funder et al. 1988) with the MR, may add another level of control of cortisol signaling through the MR.”
Aldosterone regulation of gene transcription leading to control of ion transport.
Horisberger, J. D., & Rossier, B. C. (1992) · Hypertension · doi:10.1161/01.hyp.19.3.221 · Cited by 138
Ulick, S. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.5.963 · Cited by 135
The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism
Marzolla, V., Armani, A., Zennaro, M., Cinti, F., Mammi, C., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.011 · Cited by 143
“affinity for the MR (Edwards et al., 1988; Funder et al., 1988).”
Cortisol metabolism in hypertension
Hammer, F., & Stewart, P. M. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.07.001 · Cited by 143
Metadata
- Authors
- Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I.
- Affiliations
- Medical Research Centre, Prince Henry's Hospital, Melbourne, Australia 3004.
- Venue
- Science
- Published
- 1988-10-28
- Volume
- 242
- Issue
- 4878
- Pages
- 583-585
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2148114970
- Semantic Scholar
- ae47dabb539e84fc85ea0bfd3f1a669037f37264
- Cited by
- 1,628
- References
- 19
- Citations by year
- 2026: 15 · 2025: 7 · 2024: 21 · 2023: 21 · 2022: 16 · 2021: 25 · 2020: 25 · 2019: 32 · 2018: 32 · 2017: 33 · 2016: 26 · 2015: 30 · 2014: 37 · 2013: 44 · 2012: 56
- FWCI
- 30.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- mineralocorticoid receptor, aldosterone, glucocorticoids, cortisol, corticosterone, 11β-hydroxysteroid dehydrogenase, 11-keto steroids, kidney, parotid gland, colon, hippocampus, heart
- MeSH terms
- Adrenalectomy, Aldosterone, Animals, Carbenoxolone, Colon, Corticosterone, Heart, Hippocampus, Hydrocortisone, Hydroxysteroid Dehydrogenases, Kidney, Parotid Gland, Receptors, Steroid, Receptors, Mineralocorticoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.